BioSpace News Archive

According to Scientific American, electroceuticals, a branch of neurotechnology, is one of the top 10 emerging technologies of 2018.

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2018, on Monday, November 5, 2018.

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced that it will release third quarter 2018 financial results after the market closes on Monday, November 5, 2018.

Encompass Health Corp. today reported its results of operations for the third quarter ended September 30, 2018.

Revolutionary Sensor Empowers Athletes to Optimize Workout Intensities by Measuring Muscle Oxygen Use in Real-Time

Revenue was $179.3 million in the third quarter of 2018. (Under ASC 605, net service revenue of $124.0 million increased 25.6% from net service revenue of $98.7 million for the comparable prior-year period, representing a backlog conversion rate of 21.2%.)

ISAAC, the International Society for Augmentative and Alternative Communication, has designated Octoberas Augmentative and Alternative Communication (AAC) Awareness Month.

Biotech Support Group reports on a book published by Springer, a global publisher that serves and supports the research community.

US FDA further indicates that one of the four drugs may be eligible for registration via 505(b)(2) Regulatory Pathway

ndia Globalization Capital, Inc. (NYSE American: IGC) announces today that it received a letter from the staff of NYSE Regulation informing the Company that it has determined to commence proceedings to delist the common stock of India Globalization Capital, Inc. from the Exchange